Alkermes Analyst Price Targets - Benzinga

Alkermes PLC

ALKSNASDAQ

Trade with Public

Trade with Public

$47.05

0.060.13%

Last update: Sep 1, 3:19 PM

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Options Stock Report

Alkermes Analyst Price Targets

Wall Street analyst price targets and consensus rating for Alkermes (ALKS).

Price Target Range — 12 Quarters

Analyst Consensus — 19 Analysts

16Buy

2Hold

1Sell

Consensus RatingBuy# Analysts19Avg. Consensus PT$52Upside to Avg. PT+10.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 29, 2026	JP Morgan	Jessica Fye	PT Raise	Neutral	$60→$61
Jul 29, 2026	Baird	Joel Beatty	PT Raise	Outperform	$48→$58
Jul 28, 2026	Piper Sandler	David Amsellem	PT Raise	Overweight	$43→$65
Jul 20, 2026	Stifel	Paul Matteis	PT Raise	Buy	$45→$63
Jul 13, 2026	Needham	Ami Fadia	PT Raise	Buy	$61→$62
Jul 13, 2026	JP Morgan	Jessica Fye	Reinstates	Neutral	$60
Jul 2, 2026	Mizuho	Uy Ear	PT Raise	Outperform	$53→$65
Jun 29, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Overweight	$44→$65
Jun 29, 2026	B of A Securities	Jason Gerberry	Downgrade	Neutral→Underperform	$38
Jun 24, 2026	Needham	Ami Fadia	PT Raise	Buy	$54→$61
Jun 22, 2026	TD Cowen	Joseph Thome	PT Raise	Buy	$42→$50
Jun 18, 2026	Needham	Ami Fadia	PT Raise	Buy	$50→$54
Jun 9, 2026	RBC Capital	Leonid Timashev	PT Raise	Outperform	$45→$56
May 13, 2026	Baird	Joel Beatty	PT Raise	Outperform	$45→$48
May 6, 2026	UBS	Ashwani Verma	PT Raise	Buy	$42→$48
May 6, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Overweight	$43→$44
May 6, 2026	Needham	Ami Fadia	PT Raise	Buy	$45→$50
Apr 9, 2026	B of A Securities	Jason Gerberry	PT Raise	Neutral	$34→$36
Mar 24, 2026	Piper Sandler	David Amsellem	PT Cut	Overweight	$45→$43
Feb 26, 2026	Wells Fargo	Benjamin Burnett	PT Raise	Overweight	$37→$43

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Alkermes, Raises Price Target to $61

JP Morgan analyst Jessica Fye maintains Alkermes (NASDAQ:ALKS) with a Neutral and raises the price target from $60 to $61.

Benzinga Newsdesk

PRO
Baird Maintains Outperform on Alkermes, Raises Price Target to $58

Baird analyst Joel Beatty maintains Alkermes (NASDAQ:ALKS) with a Outperform and raises the price target from $48 to $58.

Benzinga Newsdesk

PRO
Piper Sandler Reiterates Overweight on Alkermes, Raises Price Target to $65

Piper Sandler analyst David Amsellem reiterates Alkermes (NASDAQ:ALKS) with a Overweight and raises the price target from $43 to $65.

Benzinga Newsdesk

PRO
Stifel Reiterates Buy on Alkermes, Raises Price Target to $63

Stifel analyst Paul Matteis reiterates Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $45 to $63.

Benzinga Newsdesk

PRO
Needham Maintains Buy on Alkermes, Raises Price Target to $62

Needham analyst Ami Fadia maintains Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $61 to $62.

Benzinga Newsdesk

PRO
JP Morgan Reinstates Neutral on Alkermes, Announces $60 Price Target

JP Morgan analyst Jessica Fye reinstates Alkermes (NASDAQ:ALKS) with a Neutral and announces $60 price target.

Benzinga Newsdesk